Literature DB >> 183198

An ergot derivative in the treatment of Parkinson's disease.

D B Calne, I Shoulson, R Kartzinel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 183198

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.

Authors:  H R Bürki; H Asper; W Ruch; P E Züger
Journal:  Psychopharmacology (Berl)       Date:  1978-05-31       Impact factor: 4.530

2.  Coenzyme Q, peroxidation and cytochrome oxidase features after parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine.

Authors:  M Battino; G P Littarru; A Gorini; R F Villa
Journal:  Neurochem Res       Date:  1996-12       Impact factor: 3.996

3.  Parkinson-like disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in Macaca fascicularis: synaptosomal metabolism and action of dihydroergocriptine.

Authors:  R F Villa; R Arnaboldi; B Ghigini; A Gorini
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

4.  Mitochondrial factors involved in Parkinson's disease by MPTP toxicity in Macaca fascicularis and drug effect.

Authors:  R F Villa; R Arnaboldi; B Ghigini; A Gorini
Journal:  Neurochem Res       Date:  1992-11       Impact factor: 3.996

5.  New detection of brain dopamine receptors with (3H)dihydroergocryptine.

Authors:  M Tittler; P Weinreich; P Seeman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.